Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Current Assets (2016 - 2025)

Historic Current Assets for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $78.3 million.

  • Xtant Medical Holdings' Current Assets rose 969.05% to $78.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.3 million, marking a year-over-year increase of 969.05%. This contributed to the annual value of $67.1 million for FY2024, which is 346.39% up from last year.
  • Xtant Medical Holdings' Current Assets amounted to $78.3 million in Q3 2025, which was up 969.05% from $75.6 million recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year Current Assets high stood at $78.3 million for Q3 2025, and its period low was $36.6 million during Q1 2023.
  • Moreover, its 5-year median value for Current Assets was $49.4 million (2021), whereas its average is $56.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 1443.64% in 2023, then soared by 8187.06% in 2024.
  • Xtant Medical Holdings' Current Assets (Quarter) stood at $44.3 million in 2021, then grew by 11.25% to $49.3 million in 2022, then surged by 31.53% to $64.9 million in 2023, then grew by 3.46% to $67.1 million in 2024, then rose by 16.71% to $78.3 million in 2025.
  • Its last three reported values are $78.3 million in Q3 2025, $75.6 million for Q2 2025, and $69.1 million during Q1 2025.